This statement has huge implications for anticancer treatment, as it suggests that we should focus on the Akt pathway (and upon PI3K, its upstream-driving controller [58]), rather than on ERK-related cascades when pro-apoptotic strategies for controlling breast cancer are envisaged. Here, AKT1 is linked to breast cancer.